Cryo-EM enables scientists to visualize proteins at the atomic level, paving the way to accelerated discoveries in cancer research, immunology and neurodegenerative disorders.

Biological insights that might take months to generate using time-consuming lab experiments and human visual inspection can be revealed much faster using machine and deep learning.

Explore the potential of edge-to-cloud AI solutions that enable continuous capture of clinical data from study subjects using sensors and wearable devices, applying machine learning to objectively measure symptoms and quantify the impact of therapies.

TGen is an Arizona-based, nonprofit medical research institute dedicated to conducting groundbreaking research with life-changing results. TGen works to unravel the genetic components of common and complex diseases, including cancer, neurological disorders, infectious disease, and rare childhood disorders.

“Releasing GATK4 as open source was the obvious next step for our team. We believe it’s the most effective way to support the community, and we hope it continues to grow, innovate, and help researchers make insights that are essential for future human health breakthroughs.”

Significant advances in medical diagnostic imaging, software modernization and machine learning enables precise visualization of neural circuits, facilitating earlier diagnosis with higher confidence of neurodegenerative disorders including concussion, autism, multiple sclerosis and schizophrenia.

Doctors look to QIAGEN solutions to diagnose diseases and gain precise insights for better treatment decisions. Researchers rely on QIAGEN cutting-edge expertise to conquer scientific frontiers and translate genomic insights into new medi­cines. Forensic investigators, veterinarians and food safety labs depend on QIAGEN applied technologies.

“The collaboration between Aspera and Intel addresses head on the classical barriers to collaboration and scientific discovery – distance and data size – delivering on the promise of the Science DMZ, making it practical to transmit massive datasets across the WAN, removing all constraints on where the data, the analytics, and the expertise reside."

"As we learn more about the way cancer has progressed in each patient and about the effectiveness of each treatment, there will be less need for trial-and-error approaches. We will be able to say with greater certainty when treatment is necessary and which treatment will be most effective. This will help us avoid unnecessary expense and suffering."